Company Overview and News

 
Asian junk bond deluge spurs concerns about investor protection

2018-01-30 themalaymailonline
Moody’s is concerned because the decline in protection means companies have more flexibility to move assets out of reach of bondholders and increase investments in risky assets. — AFP picSINGAPORE, Jan 30 — Asian bond investors may be taking their eyes off the protections on junk bonds in the pursuit of higher yields.

 
Asia's Booming Bond Market Leaves Distressed-Debt Investors With Few Options - Bloomberg

2017-12-07 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Anton Announces First Well Completion in General Workover and Well Completion Project in Iraq

2017-03-07 prnewswire
HONG KONG, March 7, 2017 /PRNewswire/ -- Anton Oilfield Services (Group) ("Anton Oilfield Services" or "the Group") (HK: 3337), the leading independent oil and gas field technical service provider in China, is pleased to announce that the Group's general workover and well completion project in Southern Iraq market was successfully kicked off earlier on with the first well coming to a full and smooth completion today.

 
Flotek Industries' (FTK) CEO John Chisholm on Q4 2016 Results - Earnings Call Transcript

2017-02-11 seekingalpha
Good morning and welcome to the Flotek Industries Inc. Fourth Quarter 2016 Earnings Conference Call. All participants will be in a listen-only mode. There will be an opportunity for you to ask questions at the end of the company's prepared remarks. [Operator Instructions] This conference is being recorded. At this time I would now like to turn the conference over to Mr. Rich Walton, Flotek's Chief Financial Officer.

 
Antonoil Enters into Strategic Cooperation Agreement with Domestic Commercial Bank

2016-12-01 prnewswire
HONG KONG, Dec. 1, 2016 /PRNewswire/ -- Anton Oilfield Services Group ("Antonoil" or the "Group", HKEx stock code: 3337), the leading independent oilfield services provider in China, is pleased to announce that the Group has entered into a strategic cooperation agreement with Shanghai Pudong Development Bank Beijing Branch ("SPDB Bank Beijing Branch"). Pursuant to the agreement, SPDB Bank Beijing Branch will provide professional support and financing facilities, including conventional business, asset securitization, cross-border settlement, bond financing and equity transactions to the Group.

 
BRIEF-Vimpelcom says Q3 net profit down 144 pct y/y

2016-11-03 reuters
* Net profit attributable to shareholders at $445 million in Q3, down 144 percent on year;

 
UK Stocks-Factors to watch on Nov 3

2016-11-03 reuters
Nov 3 The following are the top stories in the Wall Street Journal. Reuters has not verified these stories and does not vouch for their accuracy.

 
Antonoil Enters into Strategic Cooperation Agreement with FLOTEK

2016-11-03 prnewswire
HONG KONG, Nov. 3, 2016 /PRNewswire/ -- Anton Oilfield Services Group ("Antonoil" or the "Group", HKEx stock code: 3337), the leading independent oilfield services provider in China, is pleased to announce that the Group has entered into a profound technical cooperation agreement with Flotek Chemical, LLC ("FLOTEK"). Pursuant to the agreement, FLOTEK will authorize the Group an exclusive cooperative right on its core CnF® technology.

 
BRIEF-Teekay Corp Q3 GAAP earnings per share $0.07

2016-11-03 feeds.reuters
* Anton Oilfield Services Group - appoints John William Chisholm as a non-executive director of company with effect from 2 November 2016 Source text for Eikon: Further company coverage:

 
BRIEF-Teekay Tankers Q3 GAAP loss per share of $0.03

2016-11-03 feeds.reuters
* Q3 earnings per share view $0.02 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

 
BRIEF-Teekay Offshore Partners qtrly distributable cash flow per limited partner unit $0.23

2016-11-03 feeds.reuters
* Anton Oilfield Services Group - appoints John William Chisholm as a non-executive director of company with effect from 2 November 2016 Source text for Eikon: Further company coverage:

 
BRIEF-Anton Oilfield Services Group appoints John William Chisholm as non-executive director

2016-11-03 feeds.reuters
* Anton Oilfield Services Group - appoints John William Chisholm as a non-executive director of company with effect from 2 November 2016 Source text for Eikon: Further company coverage:

 
BRIEF-Teekay LNG Partners Q3 distributable cash flow per unit $0.68

2016-11-03 feeds.reuters
* Qtrly distributable cash flow per limited partner common unit $0.68 Source text for Eikon: Further company coverage:

 
Antonoil launches coalbed methane turnkey project

2016-10-26 energyglobal
For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

 
Antonoil Successfully Launched Integrated Coalbed Methane Turnkey Project in Guizhou

2016-10-25 prnewswire
HONG KONG, Oct. 25, 2016 /PRNewswire/ -- Anton Oilfield Services Group ("Anton Oilfield Services" or the "Group"; HKEx stock code: 3337), the leading independent oil and gas field technical services supplier in China, is pleased to announce the successful launch of the integrated coalbed methane turnkey project in Guizhou covering construction and production that was won by the Group in the third quarter of the year.

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...